Report: Strategic Analysis of the ADME/TOX Technologies Market in Europe TOC

1 STRATEGIC ANALYSIS OF THE ADME/TOX TECHNOLOGIES MARKET IN EUROPE

Overview: Overview; Research Scope and Methodology; Research Scope and Methodology
Introduction and Background: Introduction and Background; Key Definitions and Abbreviations; Exchange Rates; Background and Drug Discovery Processes; Successful Drug Candidates; Secondary Screening; Failure of Lead Candidates; ADME/Toxicity Testing; Role of ADME Studies for Drug Discovery; Global ADME/Tox Screening Market Revenue; Therapeutic Efficacy and Toxicity; Drug-like Properties for ADME/TOX Studies; ADME/Tox Profiles I-II
Market Dynamics: Market and Technology Trends I & II; Industry Challenges; Using ADME/Tox to Overcome Challenges; Market Drivers; Market Restraints; Market Status and Size
Total Market Forecasts: Assumptions; Key Market Engineering Measurements; EU ADME/TOX Market Revenue Forecasts; EU ADME/TOX Market Revenue Analysis; Segmentation of ADME/TOX Market; Segmentation Revenue Forecasts; Segmentation Revenue Analysis; Company Profiles
Strategic Analysis and Recommendations: Major Challenges and Strategies; Summary of Strategic Proposals; Quotes; Market Maturation Process; Strategic Anticipation; Potential Threats; Competitive Framework; Market Potential; Three Levels Of Strategies; Pricing Strategy; Meeting the Challenge
Frost & Sullivan Awards: Frost & Sullivan Awards; Product Innovation Award; Customer Service Innovation Award; Growth Strategy Leadership Award; Market Penetration Leadership Award
Industry Participants: Industry Participants
Decision Support Databases: Decision Support Databases
Frost & Sullivan: Healthcare Team; Our Capabilities